Table 1 |
||||
|
Cell strains |
||||
|
Cell strain |
Subtype, origin |
External genitalia/ phenotype |
Age at biopsy (years; months) |
Androgen receptor |
|
|
||||
|
N-33 |
GSF, foreskin |
Normal fertile male |
51;11 |
Normal (Kd 0.08 nM, Bmax 26.40 fmol/mg protein) |
|
N-40 |
GSF, foreskin |
Normal male |
7;11 |
Normal (Kd 0.09 nM, Bmax 32.44 fmol/mg protein) |
|
N-52 |
GSF, foreskin |
Normal male |
0;3 |
Normal (Kd 0.06 nM, Bmax 35.36 fmol/mg protein) |
|
N-56 |
GSF, foreskin |
Normal fertile male |
42;10 |
Normal (Kd 0.07 nM, Bmax 13.35 fmol/mg protein) |
|
N-57 |
GSF, foreskin |
Normal male |
5;11 |
Normal (Kd 0.05 nM, Bmax 24.13 fmol/mg protein) |
|
N-58 |
GSF, foreskin |
Normal male |
5;11 |
Normal (Kd 0.10 nM, Bmax 30.61 fmol/mg protein) |
|
N-59 |
GSF, foreskin |
Normal male |
0;8 |
Normal (Kd 0.07 nM, Bmax 40.01 fmol/mg protein) |
|
N-60 |
GSF, foreskin |
Normal male |
5;4 |
Normal (Kd 0.05 nM, Bmax 20.08 fmol/mg protein) |
|
N-62 |
GSF, foreskin |
Normal male |
2;0 |
Normal (Kd 0.08 nM, Bmax 86.16 fmol/mg protein) |
|
N-AKPZF |
PRF, peripheral zone |
Normal male |
Adult |
Not investigated |
|
N-ST4 |
ASF, abdominal skin |
Normal male |
46;0 |
Not investigated |
|
N-LS12 |
FSF, forearm skin |
Normal male |
36;0 |
Not investigated |
|
ARD1097 |
GSF, labia majora |
Normal female |
1;3 |
CAIS, Pro390Ser + Arg855Gly, negative androgen binding |
|
ARD411 |
GSF, labia majora |
Normal female |
0;4 |
CAIS, Arg855Cys, negative androgen binding |
|
ARD682 |
GSF, labia majora |
Normal female |
14;10 |
CAIS, no mutation in AR-gene, negative androgen binding, no AR-protein in western immunoblot |
|
ARD402 |
GSF, labia majora |
Normal female |
1;0 |
CAIS, no mutation in AR-gene, negative androgen binding, very low AR-mRNA transcription, no AR-protein in western immunoblot |
|
ARD377 |
GSF, labia majora |
Predominantly female |
1;2 |
AIS4, Ile841Ser, (Kd 0.55 nM; Bmax 17.01 fmol/mg protein) |
|
ARD842 |
GOF, gonad |
Normal female |
38;0 |
CAIS, 26 bp deletion exon 1 (141-150), frameshift, premature stop codon, negative androgen binding |
|
ARD1004 |
GOF, gonad |
Normal female |
17;4 |
CAIS, Val866Met, negative androgen binding |
|
ARD291 |
GOF, gonad |
Normal female |
18;4 |
CAIS, Phe794Ser, negative amdrogen binding |
|
ARD531 |
GOF, gonad |
Normal female |
35,2 |
CAIS, Ala765Thr, negative androgen binding |
|
ARD557 |
GOF, gonad |
Normal female |
6;6 |
CAIS, donor splice site exon 2/intron 2, negative androgen binding |
|
ARD465 |
GSF, labia majora |
Normal female |
5;5 |
CAIS, Glu287stop, low expression of wild-type AR (Kd 0.11 nM; Bmax 3.6 fmol/mg protein), post-zygotic mutation (somatic mosaicism) |
|
ARD364 |
GSF, labia majora |
Predominantly female |
23;0 |
AIS4, Leu 172 stop, high expression of wild-type AR (Kd 0.06 nM, Bmax 22.6 fmol/mg protein), post-zygotic mutation (somatic mosaicism) (6) |
|
|
||||
|
ARD, strain-ID; ASF, abdominal skin fibroblast; FSF, forearm skin fibroblast; GOF, gonadal fibroblast; GSF, genital skin fibroblast; PRF, prostate fibroblast. Normal ranges for androgen (methyltrienolone) binding: Bmax (binding capacity): 13.35-115.98 fmol/mg protein; Kd (dissociation constant): 0.03-0.13 nM. |
||||
|
Holterhus et al. Genome Biology 2003 4:R37 doi:10.1186/gb-2003-4-6-r37 |
||||